跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,023 条关于
“ACTION3”
全部
2,023
临床试验
1,672
药物
118
机构
18
资讯
215
去年
Dimerix's ACTION3 Phase 3 Trial for FSGS Receives Positive IDMC Review
2年前
Dimerix Partners with UK National Registry to Accelerate ACTION3 Trial for FSGS
去年
Dimerix Partners with NEPTUNE to Accelerate FSGS Trial Recruitment
2年前
Dimerix's Kidney Disease Drug Trial Reaches Key Pediatric Milestone
去年
PARASOL Workshop Suggests Broader Proteinuria Endpoints for FSGS Drug Approval
去年
Dimerix's Phase 3 Trial of DMX-200 for FSGS Completes Part 2 Recruitment, Interim Analysis Expected in August 2025
2年前
Dimerix's First Patient Completes Phase 3 Trial and Enters DMX-200 Open Label Extension Study for Kidney Disease
9个月前
Dimerix Completes Recruitment for Phase 3 Trial of DMX-200 in Rare Kidney Disease FSGS
11个月前
Dimerix's DMX-200 Advances in Phase 3 FSGS Trial with Strong Safety Profile and FDA-Aligned Endpoint Data
去年
Dimerix Advances Kidney Disease Trial with Key Endpoint Validation
第 1 页,共 22 页
上一页
下一页